Does METOPROLOL Cause Malignant neoplasm progression? 191 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 191 reports of Malignant neoplasm progression have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.5% of all adverse event reports for METOPROLOL.
191
Reports of Malignant neoplasm progression with METOPROLOL
0.5%
of all METOPROLOL reports
47
Deaths
108
Hospitalizations
How Dangerous Is Malignant neoplasm progression From METOPROLOL?
Of the 191 reports, 47 (24.6%) resulted in death, 108 (56.5%) required hospitalization, and 8 (4.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 191 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which METOPROLOL Alternatives Have Lower Malignant neoplasm progression Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE